ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03220009
Brief Title: Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

First Submitted : July 17, 2017
First Submitted that Met QC Criteria : July 17, 2017
First Posted : July 18, 2017

Last Update Submitted that Met QC Criteria : October 16, 2017
Last Update Posted : October 17, 2017